TLPH
NASDAQ
$1.29
Talphera Inc (TLPH)
Talphera Inc. is a pioneering biotechnology company dedicated to advancing peptide-based therapies for rare diseases and significant unmet medical needs. Its promising pipeline, especially in developing innovative cancer treatments, highlights the firm's potential for substantial growth within the biopharmaceutical industry. Committed to rigorous research and focused on delivering transformative health solutions, Talphera represents a compelling investment opportunity for institutional investors seeking to capitalize on the dynamic biotech landscape.
Sector:
Healthcare
Strong Buy
Target: $3.17 (+145.50%)
Market Cap
$72M
Free Cash Flow Yield
-15.67%
Beta (5Y)
0.76
Price Chart
Valuation
Market Cap$72M
Forward P/E1.02
P/S74735.49
P/B3.95
Profitability
Total Revenue (TTM)$1K
Gross Profit (TTM)-$726K
EBITDA-$14M
Operating Margin-1451600%
EPS-$0.39
Financial Health
Free Cash Flow Yield-15.67%
Growth & Risk
EPS 5Y CAGR-41.25%
Revenue 5Y CAGR-82.16%
FCF 5Y CAGR-20.54%
Beta (5Y)0.76
Sharpe Ratio1.55